Keller M, Nakamura M
J Cardiovasc Aging. 2025; 4(26).
PMID: 39958699
PMC: 11827898.
DOI: 10.20517/jca.2024.21.
Mousavi N, Zhou E, Razavi A, Ebrahimi E, Varela-Castillo P, Yang X
Curr Protoc. 2025; 5(2):e70104.
PMID: 39945594
PMC: 11823567.
DOI: 10.1002/cpz1.70104.
Lumahan L, Arif M, Whitener A, Yi P
Cells. 2024; 13(2).
PMID: 38275816
PMC: 10814774.
DOI: 10.3390/cells13020191.
Chen S, Allgayer H
Cancers (Basel). 2023; 15(23).
PMID: 38067284
PMC: 10705808.
DOI: 10.3390/cancers15235580.
Wen Q, Liu H, Lou K, Zhang X, Chao W, Xin J
Mol Med Rep. 2023; 28(1).
PMID: 37293842
PMC: 10280547.
DOI: 10.3892/mmr.2023.13026.
Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer.
He K, Gan W
Cancer Manag Res. 2023; 15:435-448.
PMID: 37250384
PMC: 10224676.
DOI: 10.2147/CMAR.S411168.
Targeting bromodomain-containing proteins: research advances of drug discovery.
Pan Z, Zhao Y, Wang X, Xie X, Liu M, Zhang K
Mol Biomed. 2023; 4(1):13.
PMID: 37142850
PMC: 10159834.
DOI: 10.1186/s43556-023-00127-1.
Polyglutamine-expanded ATXN7 alters a specific epigenetic signature underlying photoreceptor identity gene expression in SCA7 mouse retinopathy.
Niewiadomska-Cimicka A, Hache A, Le Gras S, Keime C, Ye T, Eisenmann A
J Biomed Sci. 2022; 29(1):107.
PMID: 36539812
PMC: 9768914.
DOI: 10.1186/s12929-022-00892-1.
Insights into Regulators of p53 Acetylation.
Nagasaka M, Miyajima C, Aoki H, Aoyama M, Morishita D, Inoue Y
Cells. 2022; 11(23).
PMID: 36497084
PMC: 9737083.
DOI: 10.3390/cells11233825.
Natural compounds targeting nuclear receptors for effective cancer therapy.
Hegde M, Girisa S, Naliyadhara N, Kumar A, AlQahtani M, Abbas M
Cancer Metastasis Rev. 2022; 42(3):765-822.
PMID: 36482154
DOI: 10.1007/s10555-022-10068-w.
Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma.
Zhang J, Li Y, Fan T, Liu D, Zou W, Li H
Front Oncol. 2022; 12:1021558.
PMID: 36276071
PMC: 9579433.
DOI: 10.3389/fonc.2022.1021558.
Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.
Jaiswal B, Agarwal A, Gupta A
Front Endocrinol (Lausanne). 2022; 13:886594.
PMID: 36060957
PMC: 9428678.
DOI: 10.3389/fendo.2022.886594.
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs.
Muddassir M, Soni K, Sangani C, Alarifi A, Afzal M, Abduh N
RSC Adv. 2022; 11(2):612-636.
PMID: 35746919
PMC: 9133982.
DOI: 10.1039/d0ra07971e.
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression.
Xia Z, Kon N, Gu A, Tavana O, Gu W
Oncogene. 2022; 41(22):3039-3050.
PMID: 35487975
PMC: 9149126.
DOI: 10.1038/s41388-022-02331-9.
The role of epigenetic modifications in Colorectal Cancer Metastasis.
Su R, Wu X, Tao L, Wang C
Clin Exp Metastasis. 2022; 39(4):521-539.
PMID: 35429301
PMC: 9338907.
DOI: 10.1007/s10585-022-10163-w.
Water Deficit Stress Tolerance Potential of Newly Developed Wheat Genotypes for Better Yield Based on Agronomic Traits and Stress Tolerance Indices: Physio-Biochemical Responses, Lipid Peroxidation and Antioxidative Defense Mechanism.
Shahid S, Ali Q, Ali S, Al-Misned F, Maqbool S
Plants (Basel). 2022; 11(3).
PMID: 35161446
PMC: 8839292.
DOI: 10.3390/plants11030466.
Securin overexpression correlates with the activated Rb/E2F1 pathway and histone H3 epigenetic modifications in raw areca nut-induced carcinogenesis in mice.
Boruah N, Singh C, Swargiary P, Dkhar H, Chatterjee A
Cancer Cell Int. 2022; 22(1):30.
PMID: 35033090
PMC: 8761315.
DOI: 10.1186/s12935-022-02442-z.
Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer's Disease.
Maity S, Farrell K, Navabpour S, Narayanan S, Jarome T
Int J Mol Sci. 2021; 22(22).
PMID: 34830163
PMC: 8618067.
DOI: 10.3390/ijms222212280.
The related coactivator complexes SAGA and ATAC control embryonic stem cell self-renewal through acetyltransferase-independent mechanisms.
Fischer V, Plassard D, Ye T, Reina-San-Martin B, Stierle M, Tora L
Cell Rep. 2021; 36(8):109598.
PMID: 34433046
PMC: 8430043.
DOI: 10.1016/j.celrep.2021.109598.
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers.
Waddell A, Huang H, Liao D
Cancers (Basel). 2021; 13(12).
PMID: 34201346
PMC: 8229436.
DOI: 10.3390/cancers13122872.
